News & analysis
Times are shown in GMT, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS.Oncimmune Holdings PLC is a cancer detection company engaged in developing and commercializing its proprietary EarlyCDT platform technology. Its product EarlyCDT-Lung is a simple blood test to aid the risk assessment and early detection of lung cancer.
Latest ONC News
ONC Regulatory News